Single dose rasburicase in tumor lysis: One hospital's experience

Asia-Pacific Journal of Clinical Oncology

Volumn 4, Issue 1, 2008, Pages 18-20

  Steel, Simone ^a,b   Coutsouvelis, John ^a   McKendrick, Joe ^a  

^a BOX HILL HOSPITAL   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Hematological malignancy; Rasburicase; Tumor lysis syndrome

Indexed keywords

ALLOPURINOL; ELECTROLYTE; INFUSION FLUID; LACTATE DEHYDROGENASE; RASBURICASE; URIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEATH; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HOSPITAL; HUMAN; HYPERURICEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; LARGE CELL LYMPHOMA; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; RISK REDUCTION; SINGLE DRUG DOSE; TREATMENT DURATION; TUMOR LYSIS SYNDROME;

EID: 40849137851     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2008.00145.x     Document Type: Article

References (6)

1. Cairo M, Bishop M. Tumour lysis syndrome: New therapeutic strategies and classification. Br J Haematol 2004; 127: 3-11.
2. Hummel M, Buchheidt D, Reiter S. BergmannJ, Hofheinz R, Helmann R. Successful treatment of hyperuricaemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumour lysis syndrome. Leukemia 2003; 17: 2542-4.
3. Liu CY, Sims-McCallum RP, Schiffer CA. A single dose of rasburicase is sufficient for the treatment of hyperuricaemia in patients receiving chemotherapy. Leuk Res 2005; 29: 463-5.
4. Lee ACW, Chak HL, Kwan TS, Chan R. Treatment of impending tumour lysis with single dose rasburicase. Ann Pharmacother 2003; 37: 1614-7.
5. Donohoo E (ed.). Fasturtec (Rasburicase) product information. eMIMS. CMPMedica, Sydney 2006.
6. Pui C. Rasburicase: A potent uricolytic agent. Expert Opin Pharmacother 2002; 3: 433-52.